Skip to Content
Search Menu

Integrated analysis of genome and epigenome to understanding cancer

Using data to help interpreting complex mutation signatures and improve patient care in the future.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Relateret indhold

CAR-T Will Transform the Treatment of Malignant Diseases, But Challenges Remain in Selection, Logistics, and Toxicity

/ Julian Hamfjord / Jan Andreasen
CancerCAR-T

ESMO 2024: Presentations and Perspectives of New Data at Norwegian Evening

/ BestPractice Nordic
CancerESMO24

ESMO 2024: Presentations and Perspectives of New Data at Danish Evening

/ Jan Andreasen
CancerESMO24

Biotech Leader, Regeneron, Expands to the Nordics Region to Bring Innovative Medicines to Patients

/ Regeneron Pharmaceuticals
Technology

Enhancing Quality of Life in Cancer Patients and Survivors Through Behavioral Graded Activity and Psychological Therapy

/ Astrid Lahousse
CancerQuality of life
Live Fagereng

Necessary to Evaluate and Justify Off-Label Use of Oncology Drugs to Provide Equal Access to Effective Treatment

/ Live Fagereng
CancerESMO24 Play the Video 2:06
Martin Højgaard

Durable Responses and Stable Disease in Multiple ATM-Altered Advanced Cancers

/ Martin Højgaard
CancerESMO24 Play the Video 09:40

Physical Activity, Fitness, and Cardiovascular Disease Risk in Adolescent Cancer Survivors

/ Mari Bratteteig / Corina S. Rueegg / May Grydeland / Sigmund A. Anderssen / Ellen Ruud
CancerCardiovascular diseaseChildrenExercise
Christina H. Ruhlmann

Updated MASCC/ESMO Guidelines on Prevention of Cancer Therapy-Induced Nausea and Vomiting

/ Christina H. Ruhlmann
CancerChemotherapyTreatment Play the Video 7:41
Back to top